March 22, 2024

Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This study aimed to assess the clinical outcomes and risk factors for severe coronavirus disease 2019 (COVID-19) in patients with inflammatory rheumatic disease (IRD) of a national cohort.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Yurdakul et al. (Fri,) studied this question.

synapsesocial.com/papers/68e72ce0b6db6435876a6a26 https://doi.org/https://doi.org/10.46497/archrheumatol.2024.10313

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1COVID-19: clinical presentation and detection methods2021 · 51 citations
2COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population2020 · 26 citations
3Tuberculosis, BCG Vaccination, and COVID-19: Are They Connected?2022 · 8 citations
4Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry2020 · 1,179 citations
5COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).2020 · 50 citations

Preguntar a la IA

Me gusta

Guardar